How changing PEEP affects breathing drive and effort during pressure‑support ventilation
Official title: Unraveling PEEP-induced Effects on Respiratory dRivE and EFfort in Acute Hypoxemic Respiratory Failure: the REEF Study
Run by Radboud University Medical Center · NCT07203781 · Data updated 2026-11-12
We will test whether changing PEEP levels changes neural respiratory drive and inspiratory effort in adults on pressure‑support ventilation for moderate‑to‑severe ARDS or acute hypoxemic respiratory failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 1 site (Nijmegen, Gelderland) |
| Status | Recruiting |
| Started | September 2, 2025 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | November 17, 2025 |
| Trial ID | NCT07203781 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with acute hypoxemic respiratory failure (PaO2/FiO2 ≤ 200) who are on invasive pressure‑support ventilation with valid spontaneous inspiratory efforts (occlusion pressure > 5 cmH2O) and who can tolerate EIT and oesophageal/EAdi monitoring are ideal candidates.
✕Probably not a fit
Patients with pre‑existing neuromuscular disease, chronic respiratory failure requiring long‑term oxygen, ongoing muscle paralysis, pneumothorax, or contraindications to EIT or oesophageal/EAdi catheter placement are unlikely to qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an interventional physiologic protocol that changes positive end‑expiratory pressure (PEEP) in invasively ventilated adults with acute hypoxemic respiratory failure (PaO2/FiO2 ≤ 200) who are breathing with pressure support and have measurable inspiratory efforts. While patients remain on assisted ventilation, investigators will record neural and mechanical measures of breathing (for example EAdi, oesophageal pressure, and electrical impedance tomography) as PEEP is adjusted to observe short‑term effects. The protocol aims to define how PEEP alters neural respiratory drive and inspiratory effort and to explore whether these effects are driven by diaphragm geometry, lung compliance, or recruitment of expiratory muscles. Procedures are performed at a single center with advanced physiologic monitoring during brief PEEP interventions.
Why it matters
Potential benefit: If successful, the results could help clinicians choose PEEP settings that reduce harmful inspiratory effort and better protect both lung and diaphragm function.
How similar studies have gone: Previous small physiologic studies in volunteers and limited patient groups have shown mixed and heterogeneous PEEP effects on drive and effort, so this detailed simultaneous‑measurement approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Acute hypoxemic respiratory failure (AHRF) with a PaO2/FiO2-ratio ≤ 200 * Patient on invasive assisted mechanical ventilation in pressure support mode exhibiting valid inspiratory efforts (occlusion pressure \> 5 cmH2O). Exclusion Criteria: * Pre-existent neuromuscular disease * History of chronic respiratory failure requiring long-term oxygen therapy * Muscle paralysis * Pneumothorax * Contra-indication to EIT monitoring (e.g. burns, pacemaker, thoracic wounds limiting electrode placement) * Contra-indications for EAdi or oesophageal balloon catheter placement (e.g. history of gastric bypass surgery, gastro-oesophageal junction surgery, oesophageal stricture, recent upper gastrointestinal hemorrhage or known/suspected varices).
Where it's running
-
Radboudumc
Nijmegen, Gelderland, Netherlands Recruiting
Study contacts
- Principal investigator: Jonne Doorduin, PhD — Radboud University Medical Center
- Study coordinator: Tommaso Rosà, M.D.
- Email: tommaso.rosa@radboudumc.nl
- Phone: 06-50155757
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting HFNC Failure in Acute Hypoxemic Respiratory Failure using Metabolomics and Clinical Data
This study tests whether metabolomic blood profiles combined with routine clinical data can predict which adults with acute hypoxemic respiratory failure on high-flow nasal cannula will fail and need escalation of care.
-
Single-dose inhaled rh-KGF-2 for ARDS in adults
This trial tests whether a single inhaled dose of rh-KGF-2 helps adults with ARDS who are on ventilators, using three dose levels to see which is safest and potentially most effective.
-
Transpulmonary Pressure-Guided Ventilation for Right Heart Protection in ARDS
This study tests whether using transpulmonary pressure to guide ventilation can reduce right heart involvement in adults with pneumonia-related moderate to severe ARDS.
-
Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure
This study tests whether allowing spontaneous breathing or using controlled ventilation is better for adults with acute hypoxemic respiratory failure who need invasive mechanical ventilation.
-
IL-6 guided dexamethasone or tocilizumab treatment for hospitalized acute hypoxemic respiratory failure
This study will test whether measuring IL-6 to guide early treatment with dexamethasone or tocilizumab helps adults hospitalized with new acute hypoxemic respiratory failure.
-
Intubation strategies for adults with acute hypoxemic respiratory failure
This trial will test two different rules for when to intubate adults with acute hypoxemic respiratory failure to see which approach keeps patients safer while avoiding unnecessary mechanical ventilation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.